Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β

(2014) Catherine Larochelle et al.   Multiple Sclerosis Journal

Thrombotic Microangiopathy Associated with Interferon Beta

(2014) David Hunt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases

(2014) Reza Vosoughi et al.   Multiple Sclerosis and Related Disorders

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis

(2013) Julien Mahe et al.   Drug Design Development and Therapy

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

(2012) Marie Scully et al.   BRITISH JOURNAL OF HAEMATOLOGY

Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis

(2012) PJ Modrego et al.   Multiple Sclerosis Journal

Thrombotic microangiopathy and associated renal disorders

(2012) T. Barbour et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report

(2011) A. Broughton et al.   CLINICAL NEPHROLOGY